239 related articles for article (PubMed ID: 29777909)
21. The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
Xia Y; Liu Z; Yu W; Zhou S; Shao L; Song W; Liu M
PLoS One; 2018; 13(6):e0198602. PubMed ID: 29870555
[TBL] [Abstract][Full Text] [Related]
22. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis.
Serghiou S; Kyriakopoulou A; Ioannidis JP
Mol Cancer; 2016 Jun; 15(1):50. PubMed ID: 27352941
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNAs as potential biomarkers and therapeutic targets in gallbladder cancer: a systematic review and meta-analysis.
Zhong Y; Wu X; Li Q; Ge X; Wang F; Wu P; Deng X; Miao L
Cancer Cell Int; 2019; 19():169. PubMed ID: 31297033
[TBL] [Abstract][Full Text] [Related]
25. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas.
Isaev K; Jiang L; Wu S; Lee CA; Watters V; Fort V; Tsai R; Coutinho FJ; Hussein SMI; Zhang J; Wu J; Dirks PB; Schramek D; Reimand J
Cell Rep; 2021 Oct; 37(3):109873. PubMed ID: 34686327
[TBL] [Abstract][Full Text] [Related]
26. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Liu X; Chen L; Xu Z; Shao J
Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
[TBL] [Abstract][Full Text] [Related]
27. Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.
Hu C; Zhou Y; Liu C; Kang Y
Oncol Rep; 2018 Nov; 40(5):2467-2476. PubMed ID: 30106138
[TBL] [Abstract][Full Text] [Related]
28. Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells.
Wang L; He Z
Med Sci Monit; 2019 Oct; 25():7567-7573. PubMed ID: 31593561
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
Tian X; Xu G
BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
Zhou Y; Wang DL; Pang Q
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
[TBL] [Abstract][Full Text] [Related]
31. LncRNA as potential biomarker and therapeutic target in glioma.
Xu X; Liang Y; Gareev I; Liang Y; Liu R; Wang N; Yang G
Mol Biol Rep; 2023 Jan; 50(1):841-851. PubMed ID: 36331751
[TBL] [Abstract][Full Text] [Related]
32. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis.
Wei Y; Niu B
Dis Markers; 2015; 2015():164635. PubMed ID: 26420912
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
[TBL] [Abstract][Full Text] [Related]
35. Long Noncoding RNA UCA1 Overexpression Is Associated with Poor Prognosis in Digestive System Malignancies: A Meta-analysis.
Shi FT; Chen LD; Zhang LF
Curr Med Sci; 2019 Oct; 39(5):694-701. PubMed ID: 31612385
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer.
Zhu J; Kong F; Xing L; Jin Z; Li Z
Clin Chim Acta; 2018 Apr; 479():43-47. PubMed ID: 29307668
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
Chi S; Shen L; Hua T; Liu S; Zhuang G; Wang X; Zhou X; Wang G; Wang H
Oncotarget; 2017 Oct; 8(45):79061-79072. PubMed ID: 29108287
[TBL] [Abstract][Full Text] [Related]
38. The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis.
Jing W; Li N; Wang Y; Liu X; Liao S; Chai H; Tu J
Oncotarget; 2017 Jan; 8(3):3957-3968. PubMed ID: 27992369
[TBL] [Abstract][Full Text] [Related]
39. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
40. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
Jing SY; Lu YY; Yang JK; Deng WY; Zhou Q; Jiao BH
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3992-3996. PubMed ID: 27775801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
